This is a biopharmaceutical company engaged in developing and commercialising its proprietary plant cell-based expression system, ProCellEx. In addition, it manufactures Elelyso, an approved product for treating Gaucher disease.
This is a biopharmaceutical company engaged in developing and commercialising its proprietary plant cell-based expression system, ProCellEx. In addition, it manufactures Elelyso, an approved product for treating Gaucher disease.